100
Participants
Start Date
August 26, 2022
Primary Completion Date
April 16, 2024
Study Completion Date
April 16, 2024
Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
Injection, 2mg (equivalent to 50 µL solution for injection)
Dr. R.P. Centre for Ophthalmic Sciences, AIIMS, New Delhi
Post Graduate Institute of Medical Education and Research, Chandigarh
M & J Western Regional Institute of Ophthalmology, Ahmedabad
Raghudeep Eye Hospital, Ahmedabad
L.V. Prasad Eye Institute, Hyderabad
Narayana Nethralaya, Bengaluru
Sankara Eye Hospital, Bengaluru
Medical Research Foundation, Sankara Nethralaya, Chennai
Lotus Eye Hospital and Institute, Coimbatore
Disha Eye Hospitals, Kolkata
Lead Sponsor
Bayer
INDUSTRY